APA (7th ed.) Citation

D'Angelo, S. P., Lebbe, C., Mortier, L., Brohl, A. S., Fazio, N., Grob, J., . . . Nghiem, P. (2021). First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): Primary and biomarker analyses of a phase II study. Journal for ImmunoTherapy of Cancer, 9(7), . https://doi.org/10.1136/jitc-2021-002646

Chicago Style (17th ed.) Citation

D'Angelo, Sandra P., et al. "First-line Avelumab in a Cohort of 116 Patients with Metastatic Merkel Cell Carcinoma (JAVELIN Merkel 200): Primary and Biomarker Analyses of a Phase II Study." Journal for ImmunoTherapy of Cancer 9, no. 7 (2021). https://doi.org/10.1136/jitc-2021-002646.

MLA (9th ed.) Citation

D'Angelo, Sandra P., et al. "First-line Avelumab in a Cohort of 116 Patients with Metastatic Merkel Cell Carcinoma (JAVELIN Merkel 200): Primary and Biomarker Analyses of a Phase II Study." Journal for ImmunoTherapy of Cancer, vol. 9, no. 7, 2021, https://doi.org/10.1136/jitc-2021-002646.